Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
41.61
+0.72 (1.76%)
Apr 13, 2026, 1:32 PM EDT - Market open
Qiagen Revenue
In the year 2025, Qiagen had annual revenue of $2.09B with 5.65% growth. Qiagen had revenue of $540.42M in the quarter ending December 31, 2025, with 3.69% growth.
Revenue (ttm)
$2.09B
Revenue Growth
+5.65%
P/S Ratio
4.09
Revenue / Employee
$366,666
Employees
5,700
Market Cap
8.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.09B | 111.79M | 5.65% |
| Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | 1.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Charles River Laboratories International | 4.02B |
| Revvity | 2.86B |
| Medpace Holdings | 2.53B |
| RadNet | 2.04B |
QGEN News
- 13 days ago - Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis - Business Wire
- 24 days ago - Qiagen Announces Form 20-F Annual Report Filing for 2025 Results - Business Wire
- 24 days ago - QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention - Business Wire
- 4 weeks ago - QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System - Business Wire
- 7 weeks ago - Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery - Business Wire
- 2 months ago - QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars - Business Wire
- 2 months ago - QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026 - Business Wire
- 2 months ago - QIAGEN Appoints Mark Stevenson to Supervisory Board - Business Wire